N-Allyl-4-chloronicotinamide

Catalog No.: 
ACYEBZ576
CAS No.: 
62458-87-1
Molecular Formula: 
C9H9ClN2O
Molecular Weight: 
196.64
N-Allyl-4-chloronicotinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$84.00InquiryInquiry
1g95%$263.00InquiryInquiry
5g95%$1289.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Allyl-4-chloronicotinamide
IUPAC NameN-allyl-4-chloronicotinamide
Molecular FormulaC9H9ClN2O
Molecular Weight196.64
SMILESO=C(C1=C(Cl)C=CN=C1)NCC=C
InChI KeyRGNCOSHHPFQSJX-UHFFFAOYSA-N
Synonym3-Pyridinecarboxamide, 4-chloro-N-2-propen-1-yl-
CAS No.62458-87-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYEBZ576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXLTP679 route compound structure diagram
    ACXLTP67910017-11-5In Stock
  2. Plus
  3. ACPVJZ912 route compound structure diagram
    ACPVJZ91210177-29-4In Stock
  4. Then
  5. ACYEBZ576 route product structure diagram
    ACYEBZ57662458-87-1
Inquiry

2. ACYEBZ576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXLTP679 route compound structure diagram
    ACXLTP67910017-11-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYEBZ576 route product structure diagram
    ACYEBZ57662458-87-1
Inquiry

3. ACYEBZ576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXLTP679 route compound structure diagram
    ACXLTP67910017-11-5In Stock
  2. Plus
  3. ACUQSO610 route compound structure diagram
    ACUQSO61063592-85-8
  4. Then
  5. ACYEBZ576 route product structure diagram
    ACYEBZ57662458-87-1
Inquiry

Comments (0)